Choline PET/CT for imaging prostate canceran update

K. Kitajima, M. C. Robert, N. A. Mark, Akira Kawashima

Research output: Contribution to journalArticle

Abstract

Whole-body integrated positron emission tomogra-phy/computed tomography (PET/CT) with [11C] -and 18F -labeled choline derivates has emerged as a promising molecular imaging modality for the evaluation of prostate cancer. 11C- and 18F-choline PET/CT are used successfully for restaging prostate cancer in patients with biochemical recurrence of disease after definitive therapy, and this correct diagnosis impacts subsequent management, such as consideration of salvage therapy for local recurrence or systemic treatment for metastatic disease. 11C- and 18F-choline PET/ CT have more limited roles for the initial staging of prostate cancer due to the low spatial resolution inherent to PET. Overall, these modalities are most useful in patients with a high pre-test suspicion of metastatic disease. The present review discusses the current role of 11C- and 18F-choline PET/CT in the management of prostate cancer, discussing its usefulness and limitations in the imaging of these patients.

Original languageEnglish (US)
Pages (from-to)279-288
Number of pages10
JournalJapanese Journal of Clinical Radiology
Volume59
Issue number2
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Choline
Prostate
Prostatic Neoplasms
Tomography
Electrons
Recurrence
Salvage Therapy
Molecular Imaging
fluoromethylcholine
Therapeutics

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Choline PET/CT for imaging prostate canceran update. / Kitajima, K.; Robert, M. C.; Mark, N. A.; Kawashima, Akira.

In: Japanese Journal of Clinical Radiology, Vol. 59, No. 2, 01.01.2014, p. 279-288.

Research output: Contribution to journalArticle

Kitajima, K, Robert, MC, Mark, NA & Kawashima, A 2014, 'Choline PET/CT for imaging prostate canceran update', Japanese Journal of Clinical Radiology, vol. 59, no. 2, pp. 279-288.
Kitajima, K. ; Robert, M. C. ; Mark, N. A. ; Kawashima, Akira. / Choline PET/CT for imaging prostate canceran update. In: Japanese Journal of Clinical Radiology. 2014 ; Vol. 59, No. 2. pp. 279-288.
@article{c2ca1366787f48bc941bf2b855c7c499,
title = "Choline PET/CT for imaging prostate canceran update",
abstract = "Whole-body integrated positron emission tomogra-phy/computed tomography (PET/CT) with [11C] -and 18F -labeled choline derivates has emerged as a promising molecular imaging modality for the evaluation of prostate cancer. 11C- and 18F-choline PET/CT are used successfully for restaging prostate cancer in patients with biochemical recurrence of disease after definitive therapy, and this correct diagnosis impacts subsequent management, such as consideration of salvage therapy for local recurrence or systemic treatment for metastatic disease. 11C- and 18F-choline PET/ CT have more limited roles for the initial staging of prostate cancer due to the low spatial resolution inherent to PET. Overall, these modalities are most useful in patients with a high pre-test suspicion of metastatic disease. The present review discusses the current role of 11C- and 18F-choline PET/CT in the management of prostate cancer, discussing its usefulness and limitations in the imaging of these patients.",
author = "K. Kitajima and Robert, {M. C.} and Mark, {N. A.} and Akira Kawashima",
year = "2014",
month = "1",
day = "1",
language = "English (US)",
volume = "59",
pages = "279--288",
journal = "Japanese Journal of Clinical Radiology",
issn = "0009-9252",
publisher = "Kanehara Shuppan Co. Ltd",
number = "2",

}

TY - JOUR

T1 - Choline PET/CT for imaging prostate canceran update

AU - Kitajima, K.

AU - Robert, M. C.

AU - Mark, N. A.

AU - Kawashima, Akira

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Whole-body integrated positron emission tomogra-phy/computed tomography (PET/CT) with [11C] -and 18F -labeled choline derivates has emerged as a promising molecular imaging modality for the evaluation of prostate cancer. 11C- and 18F-choline PET/CT are used successfully for restaging prostate cancer in patients with biochemical recurrence of disease after definitive therapy, and this correct diagnosis impacts subsequent management, such as consideration of salvage therapy for local recurrence or systemic treatment for metastatic disease. 11C- and 18F-choline PET/ CT have more limited roles for the initial staging of prostate cancer due to the low spatial resolution inherent to PET. Overall, these modalities are most useful in patients with a high pre-test suspicion of metastatic disease. The present review discusses the current role of 11C- and 18F-choline PET/CT in the management of prostate cancer, discussing its usefulness and limitations in the imaging of these patients.

AB - Whole-body integrated positron emission tomogra-phy/computed tomography (PET/CT) with [11C] -and 18F -labeled choline derivates has emerged as a promising molecular imaging modality for the evaluation of prostate cancer. 11C- and 18F-choline PET/CT are used successfully for restaging prostate cancer in patients with biochemical recurrence of disease after definitive therapy, and this correct diagnosis impacts subsequent management, such as consideration of salvage therapy for local recurrence or systemic treatment for metastatic disease. 11C- and 18F-choline PET/ CT have more limited roles for the initial staging of prostate cancer due to the low spatial resolution inherent to PET. Overall, these modalities are most useful in patients with a high pre-test suspicion of metastatic disease. The present review discusses the current role of 11C- and 18F-choline PET/CT in the management of prostate cancer, discussing its usefulness and limitations in the imaging of these patients.

UR - http://www.scopus.com/inward/record.url?scp=84895797868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895797868&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84895797868

VL - 59

SP - 279

EP - 288

JO - Japanese Journal of Clinical Radiology

JF - Japanese Journal of Clinical Radiology

SN - 0009-9252

IS - 2

ER -